As of 2024-12-15, the Relative Valuation of N4 Pharma PLC (N4P.L) is (6.46) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 0.60 GBP, the upside of N4 Pharma PLC based on Relative Valuation is -1176.8%.
The range of the Relative Valuation is (5.65) - (6.76) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 30.7x | 23.0x |
| Forward P/E multiples | 19.9x - 23.8x | 22.4x |
| Fair Price | (5.65) - (6.76) | (6.46) |
| Upside | -1041.0% - -1226.8% | -1176.8% |
| Date | P/E |
| 2024-11-20 | -2.29 |
| 2024-11-19 | -2.29 |
| 2024-11-18 | -2.29 |
| 2024-11-15 | -2.29 |
| 2024-11-14 | -2.29 |
| 2024-11-13 | -2.37 |
| 2024-11-12 | -2.37 |
| 2024-11-11 | -2.29 |
| 2024-11-08 | -2.20 |
| 2024-11-07 | -2.29 |
| 2024-11-06 | -2.46 |
| 2024-11-05 | -2.64 |
| 2024-11-04 | -2.55 |
| 2024-11-01 | -2.20 |
| 2024-10-31 | -2.29 |
| 2024-10-30 | -2.20 |
| 2024-10-29 | -2.11 |
| 2024-10-28 | -2.11 |
| 2024-10-25 | -1.93 |
| 2024-10-24 | -2.11 |
| 2024-10-23 | -2.11 |
| 2024-10-22 | -2.11 |
| 2024-10-21 | -2.11 |
| 2024-10-18 | -2.11 |
| 2024-10-17 | -2.11 |
| 2024-10-16 | -2.11 |
| 2024-10-15 | -2.11 |
| 2024-10-14 | -2.11 |
| 2024-10-11 | -2.11 |
| 2024-10-10 | -2.02 |
| 2024-10-09 | -1.93 |
| 2024-10-08 | -1.93 |
| 2024-10-07 | -1.93 |
| 2024-10-04 | -1.93 |
| 2024-10-03 | -2.11 |
| 2024-10-02 | -2.15 |
| 2024-10-01 | -1.93 |
| 2024-09-30 | -1.93 |
| 2024-09-27 | -1.93 |
| 2024-09-26 | -1.93 |
| 2024-09-25 | -2.11 |
| 2024-09-24 | -2.02 |
| 2024-09-23 | -1.93 |
| 2024-09-20 | -1.93 |
| 2024-09-19 | -1.93 |
| 2024-09-18 | -2.02 |
| 2024-09-17 | -1.85 |
| 2024-09-16 | -1.85 |
| 2024-09-13 | -1.85 |
| 2024-09-12 | -1.85 |